CKD患者生活质量与肾功能关系的交叉滞后分析。

IF 4.4 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Graziella D'Arrigo, Mercedes Gori, Carmela Marino, Patrizia Pizzini, Graziella Caridi, Francesco Marino, Giovanna Parlongo, Annalisa Pitino, Giovanni S F Bruno, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali
{"title":"CKD患者生活质量与肾功能关系的交叉滞后分析。","authors":"Graziella D'Arrigo, Mercedes Gori, Carmela Marino, Patrizia Pizzini, Graziella Caridi, Francesco Marino, Giovanna Parlongo, Annalisa Pitino, Giovanni S F Bruno, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali","doi":"10.1111/eci.70087","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD) significantly impacts patient well-being, with declining glomerular filtration rate (eGFR) often leading to worsening quality of life (QoL). However, the directionality of the eGFR-QoL relationship remains unclear due to limitations of prior cross-sectional and longitudinal studies.</p><p><strong>Methods: </strong>This study applied cross-lagged analysis to investigate the reciprocal relationship between eGFR and QoL (measured using SF-36 Physical and Mental Component Scores [PCS and MCS]) over 36 months in 422 CKD patients recruited from nephrology units in Southern Italy. Generalized Method of Moments (GMM) models tested two hypotheses: (1) PCS as a determinant of MCS, or vice versa; and (2) eGFR as a determinant of MCS/PCS, or vice versa.</p><p><strong>Results: </strong>Cross-lagged analysis confirmed that lower eGFR significantly predicted declines in both PCS and MCS in subsequent visits (p < .05). At the same time, the reverse relationship (QoL affecting eGFR) was not statistically significant. Multivariable models, adjusting for potential confounders including demographic factors, comorbidities, and socioeconomic status, confirmed these findings.</p><p><strong>Conclusion: </strong>Kidney function decline leads to worsening QoL, whereas deterioration in QoL does not impact eGFR decline. These findings support prioritising interventions that slow the progression of CKD as a means to preserve quality of life. This study highlights the utility of cross-lagged analysis in nephrology research and underscores the importance of early chronic kidney disease (CKD) management to maintain patient well-being.</p>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":" ","pages":"e70087"},"PeriodicalIF":4.4000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A cross-lagged analysis of the relationship between quality of life and kidney function in CKD patients.\",\"authors\":\"Graziella D'Arrigo, Mercedes Gori, Carmela Marino, Patrizia Pizzini, Graziella Caridi, Francesco Marino, Giovanna Parlongo, Annalisa Pitino, Giovanni S F Bruno, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali\",\"doi\":\"10.1111/eci.70087\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chronic kidney disease (CKD) significantly impacts patient well-being, with declining glomerular filtration rate (eGFR) often leading to worsening quality of life (QoL). However, the directionality of the eGFR-QoL relationship remains unclear due to limitations of prior cross-sectional and longitudinal studies.</p><p><strong>Methods: </strong>This study applied cross-lagged analysis to investigate the reciprocal relationship between eGFR and QoL (measured using SF-36 Physical and Mental Component Scores [PCS and MCS]) over 36 months in 422 CKD patients recruited from nephrology units in Southern Italy. Generalized Method of Moments (GMM) models tested two hypotheses: (1) PCS as a determinant of MCS, or vice versa; and (2) eGFR as a determinant of MCS/PCS, or vice versa.</p><p><strong>Results: </strong>Cross-lagged analysis confirmed that lower eGFR significantly predicted declines in both PCS and MCS in subsequent visits (p < .05). At the same time, the reverse relationship (QoL affecting eGFR) was not statistically significant. Multivariable models, adjusting for potential confounders including demographic factors, comorbidities, and socioeconomic status, confirmed these findings.</p><p><strong>Conclusion: </strong>Kidney function decline leads to worsening QoL, whereas deterioration in QoL does not impact eGFR decline. These findings support prioritising interventions that slow the progression of CKD as a means to preserve quality of life. This study highlights the utility of cross-lagged analysis in nephrology research and underscores the importance of early chronic kidney disease (CKD) management to maintain patient well-being.</p>\",\"PeriodicalId\":12013,\"journal\":{\"name\":\"European Journal of Clinical Investigation\",\"volume\":\" \",\"pages\":\"e70087\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Clinical Investigation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/eci.70087\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/eci.70087","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:慢性肾脏疾病(CKD)显著影响患者的健康,肾小球滤过率(eGFR)下降往往导致生活质量(QoL)恶化。然而,由于先前横断面和纵向研究的局限性,eGFR-QoL关系的方向性尚不清楚。方法:本研究采用交叉滞后分析,调查从意大利南部肾内科招募的422名CKD患者在36个月内eGFR与生活质量(使用SF-36生理和心理成分评分[PCS和MCS]测量)之间的相互关系。广义矩量法(GMM)模型检验了两个假设:(1)PCS是MCS的决定因素,反之亦然;(2) eGFR作为MCS/PCS的决定因素,反之亦然。结果:交叉滞后分析证实,较低的eGFR显著预测了随后就诊中PCS和MCS的下降(p结论:肾功能下降导致生活质量恶化,而生活质量恶化并不影响eGFR下降。这些发现支持将减缓CKD进展的干预措施作为维持生活质量的一种手段。本研究强调了交叉滞后分析在肾脏病学研究中的应用,并强调了早期慢性肾脏疾病(CKD)管理对维持患者健康的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A cross-lagged analysis of the relationship between quality of life and kidney function in CKD patients.

Background: Chronic kidney disease (CKD) significantly impacts patient well-being, with declining glomerular filtration rate (eGFR) often leading to worsening quality of life (QoL). However, the directionality of the eGFR-QoL relationship remains unclear due to limitations of prior cross-sectional and longitudinal studies.

Methods: This study applied cross-lagged analysis to investigate the reciprocal relationship between eGFR and QoL (measured using SF-36 Physical and Mental Component Scores [PCS and MCS]) over 36 months in 422 CKD patients recruited from nephrology units in Southern Italy. Generalized Method of Moments (GMM) models tested two hypotheses: (1) PCS as a determinant of MCS, or vice versa; and (2) eGFR as a determinant of MCS/PCS, or vice versa.

Results: Cross-lagged analysis confirmed that lower eGFR significantly predicted declines in both PCS and MCS in subsequent visits (p < .05). At the same time, the reverse relationship (QoL affecting eGFR) was not statistically significant. Multivariable models, adjusting for potential confounders including demographic factors, comorbidities, and socioeconomic status, confirmed these findings.

Conclusion: Kidney function decline leads to worsening QoL, whereas deterioration in QoL does not impact eGFR decline. These findings support prioritising interventions that slow the progression of CKD as a means to preserve quality of life. This study highlights the utility of cross-lagged analysis in nephrology research and underscores the importance of early chronic kidney disease (CKD) management to maintain patient well-being.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.50
自引率
3.60%
发文量
192
审稿时长
1 months
期刊介绍: EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信